TAMPA, FL — The Florida Multiple Sclerosis (MS) Conference 2026 will take place on Saturday, July 25, 2026, from 7:00 AM to 5:00 PM at the Omni Orlando Resort, 1500 Master Blvd., ChampionsGate, FL. The one-day educational conference is designed for academic and community neurologists, advanced practice providers (APPs), MS specialists, and medical professionals involved in the diagnosis, treatment, and long-term management of patients with multiple sclerosis and related demyelinating disorders.
Attendees may earn up to 6.5 AMA PRA Category 1 Credit(s) while learning from leading MS and neuroimmunology experts from institutions and neurology practices across Florida. The program will cover clinically relevant topics including early diagnosis, biomarkers and imaging, treatment strategies, progressive MS, pregnancy and family planning, symptom management, immune reconstitution, HSCT and CAR-T, NMOSD and MOGAD, and the connection between academic and community MS care.
The conference will be led by Course Director Linga Vinay Reddy, MD, PhD, with a Steering Committee that includes Torge Rempe, MD, PhD of the University of Florida, John Ciotti, MD of the University of South Florida, Leticia Tornes, MD, FAAN of the University of Miami, Vanessa Marin, MD of Mayo Clinic, and Daniel Jacobs, MD of the University of Central Florida.
Distinguished speakers include Dr. Linga Reddy, First Choice Neurology; Dr. John Ciotti, USF; Dr. Elsa Rodriguez, Cleveland Clinic; Dr. Torge Rempe, UF Gainesville; Dr. Mayra Montalvo, UF Gainesville; Dr. Vanessa Marin Collazo, Mayo Clinic; Dr. Matthew Baker, Collier Neurologic Specialists; Dr. Donald Negroski, Negroski Neurology; Dr. Abu-Sayeef Mirza, Moffitt Cancer Center; Dr. Aisha Elfasi, USF; and Dr. Freddy Escobar, OrlandoHealth, UF Gainesville.
Attendees of the Florida Multiple Sclerosis Conference can expect clinically useful education that supports day-to-day practice. The program will address questions such as:
- How can biomarkers and imaging improve early MS diagnosis?
- When should clinicians consider early high-efficacy therapy instead of escalation?
- How should progressive MS be monitored and treated?
- What should neurologists know about pregnancy and family planning in MS?
- How can clinicians recognize progression independent of relapse?
- What is the emerging role of HSCT, CAR-T, and immune reconstitution in MS?
- How should NMOSD and MOGAD be differentiated from MS?
- How can academic and community providers collaborate more effectively across Florida?
By the end of the program, participants should be better equipped to apply emerging evidence, evaluate complex MS cases, and improve continuity of care for patients throughout Florida.
“Multiple Sclerosis care is changing rapidly, and clinicians need access to the latest research, treatment strategies, and collaborative care models,” said Linga Reddy, MD, PhD, Course Director of the Florida Multiple Sclerosis Conference and neurologist with First Choice Neurology. “This conference is designed to help neurologists and advanced practice providers apply new insights in MS diagnosis and treatment to improve care for patients in their own communities.”
Secure your spot to earn 6.5 CME credits and save with early registration, visit https://neuroevents.org/.
